Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
The study protocol is designed with three key components: 1. Build on existing PARI outpatient syndromic surveillance by adding laboratory multiplex testing of LRTI samples (RSV, Influenza, SARS-COV-2) 2. Follow all bronchiolitis through the PARI RWE database and document "patient journey" for 5 years after first medical visit 3. Review the electronic PARI data of three previous seasons in order to document the impact of LRTI attributable to RSV in children \< 2 years in France prior to enhanced surveillance
Study Type
OBSERVATIONAL
Enrollment
3,500
rapid antigen test for Sars Cov-2, influenza and RSV. multiplex RT-PCR for a subgroup of 500 patients
ACTIV
Créteil, France
RECRUITINGRSV proven
Percentage of children with proven RSV disease (bronchiolitis, AOM or pneumonia)
Time frame: day of enrrollement
Proportion of Respiratory Tract Infections by RSV Status
Percentage of children with Respiratory Tract Infections by RSV Status
Time frame: day of enrrollement
Proportion of Respiratory Tract Infections with SARS-CoV-2
Percentage of children with Respiratory Tract Infections with SARS-CoV-2
Time frame: day of enrrollement
Proportion of associated complications by RSV status
Percentage of children with associated complications by RSV status
Time frame: day of enrrollement, 15 days and 6 months
Proportion of AOM by RSV status
Percentage of children with AOM by RSV status
Time frame: day of enrrollement
Proportion of pneumonia by RSV status
Percentage of children with pneumonia by RSV status
Time frame: day of enrrollement
Score of Quality of life
Assessed by the quality of life infant scale (from 0-100, so that higher scores indicate better Health-Related Quality of Life)
Time frame: 15 days and 6 months
Caracteristic of tests
Sensitivity, specificity, positive predictive value, negative predictive value positive and negative likelihood ratio of the SARS-Cov2, influenza A/B and RSV rapid antigenic test compared to the reference test by multiplex RT-PCR
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: day of enrrollement